Supporting may also be the BPC 157-induced decrease of the inflammatory mediators, leukotriene B4 (LTB4), thromboxane B2 (TXB2), and myeloperoxidase (MPO), in both serum and inflamed tissue [40], largely implicated in heparin-induced platelet activation, the adhesion of leukocytes to the endothelium and concomitant increase in vascular permeability [41], prolongation of the bleeding time [42] while low-molecular-weight heparin enoxaparin causes systemic MPO activation [43]
Its broad range of effects suggests potential applications for tissue regeneration, gut health, neurological conditions, cardiovascular protection, and chronic pain management
Search PubMed Briere DA, et al
Legal gray area: Not approved for medical use
Shipping and Order Information PSPeptides ships retatrutide to all 50 US states and US territories